Ajinomoto

Ajinomoto is a global manufacturer focused on seasonings, processed foods, beverages, amino acids, pharmaceuticals, and specialty chemicals. It applies amino acid technologies to support food resources, human health, and sustainable development, while producing consumer products such as dry soup mixes, frozen foods, and beverages and supplying monosodium glutamate and nucleotides to multinational food producers. The business is organized into three segments: Seasonings & Foods, Frozen Foods, and Health Care and Other, with the majority of revenue from Seasonings & Foods. The company also provides pharmaceutical ingredients, biopharmaceutical services, and functional materials, serving customers worldwide across food, nutrition, and health markets.

Ryuichi Mihara

Associate General Manager

Past deals in Dietary Supplements

Enhanced Medical Nutrition

Series A in 2025
Enhanced Medical Nutrition specializes in the development of medical food products aimed at improving patient outcomes related to surgery. The company focuses on research, development, and distribution of evidence-based clinical nutrition specifically designed for the perioperative setting. Their products assist in rehabilitation, promote wound healing, and manage the protein needs of individuals who are ill and aging. By utilizing their innovative medical foods, Enhanced Medical Nutrition enables patients to reduce postoperative insulin resistance and enhance overall health during recovery periods.

Ajinomoto

Acquisition in 2023
Ajinomoto is a global manufacturer focused on seasonings, processed foods, beverages, amino acids, pharmaceuticals, and specialty chemicals. It applies amino acid technologies to support food resources, human health, and sustainable development, while producing consumer products such as dry soup mixes, frozen foods, and beverages and supplying monosodium glutamate and nucleotides to multinational food producers. The business is organized into three segments: Seasonings & Foods, Frozen Foods, and Health Care and Other, with the majority of revenue from Seasonings & Foods. The company also provides pharmaceutical ingredients, biopharmaceutical services, and functional materials, serving customers worldwide across food, nutrition, and health markets.

Cambrooke Therapeutics

Acquisition in 2017
Cambrooke Therapeutics develops and manufactures therapeutic nutrition products administered under medical supervision for patients needing specialized dietary therapies. Their products focus on natural intact protein designed for metabolic disorders, renal diseases, and phenylketonuria, supporting dietary management by providing targeted protein nutrition for individuals who cannot adequately metabolize certain amino acids. The company aims to improve treatment outcomes and the dietary experience for patients requiring clinically supervised diets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.